gclc

gclc

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f8f9fa;text-align:center;font-size:1.1em;">GCLC</th></tr>
<tr><th>Symbol</th><td>GCLC</td></tr>
<tr><th>Full Name</th><td>Glutamate-Cysteine Ligase Catalytic Subunit</td></tr>
<tr><th>Chromosome</th><td>6p12.3</td></tr>
<tr><th>NCBI Gene ID</th><td>[2729](https://www.ncbi.nlm.nih.gov/gene/2729)</td></tr>
<tr><th>OMIM</th><td>[606483](https://www.omim.org/entry/606483)</td></tr>
<tr><th>Ensembl</th><td>[ENSG00000001036](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000001036)</td></tr>
<tr><th>UniProt</th><td>[P48506](https://www.uniprot.org/uniprot/P48506)</td></tr>
<tr><th>Associated Diseases</th><td>Alzheimer's Disease, Parkinson's Disease, ALS, Oxidative Stress-Related Disorders</td></tr>
</table>
</div>

Overview

GCLC (Glutamate-Cysteine Ligase Catalytic Subunit) encodes the catalytic subunit of glutamate-cysteine ligase (GCL), also known as γ-glutamylcysteine synthetase, which is the rate-limiting enzyme in glutathione biosynthesis. Located on chromosome 6p12.3, GCLC encodes the larger subunit (about 73 kDa) of the heterodimeric GCL enzyme. Together with the modifier subunit (GCLM), GCLC forms the functional enzyme that catalyzes the first and rate-limiting step in glutathione synthesis: the ATP-dependent formation of γ-glutamylcysteine from glutamate and cysteine. This reaction is absolutely required for cellular glutathione production, making GCLC essential for antioxidant defense and redox homeostasis in all tissues, including the brain [@lu1999].

gclc

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f8f9fa;text-align:center;font-size:1.1em;">GCLC</th></tr>
<tr><th>Symbol</th><td>GCLC</td></tr>
<tr><th>Full Name</th><td>Glutamate-Cysteine Ligase Catalytic Subunit</td></tr>
<tr><th>Chromosome</th><td>6p12.3</td></tr>
<tr><th>NCBI Gene ID</th><td>[2729](https://www.ncbi.nlm.nih.gov/gene/2729)</td></tr>
<tr><th>OMIM</th><td>[606483](https://www.omim.org/entry/606483)</td></tr>
<tr><th>Ensembl</th><td>[ENSG00000001036](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000001036)</td></tr>
<tr><th>UniProt</th><td>[P48506](https://www.uniprot.org/uniprot/P48506)</td></tr>
<tr><th>Associated Diseases</th><td>Alzheimer's Disease, Parkinson's Disease, ALS, Oxidative Stress-Related Disorders</td></tr>
</table>
</div>

Overview

GCLC (Glutamate-Cysteine Ligase Catalytic Subunit) encodes the catalytic subunit of glutamate-cysteine ligase (GCL), also known as γ-glutamylcysteine synthetase, which is the rate-limiting enzyme in glutathione biosynthesis. Located on chromosome 6p12.3, GCLC encodes the larger subunit (about 73 kDa) of the heterodimeric GCL enzyme. Together with the modifier subunit (GCLM), GCLC forms the functional enzyme that catalyzes the first and rate-limiting step in glutathione synthesis: the ATP-dependent formation of γ-glutamylcysteine from glutamate and cysteine. This reaction is absolutely required for cellular glutathione production, making GCLC essential for antioxidant defense and redox homeostasis in all tissues, including the brain [@lu1999].

Glutathione (GSH) is the most abundant low-molecular-weight antioxidant in cells, serving critical functions including detoxification of reactive oxygen species (ROS), maintenance of redox balance, and participation in numerous cellular metabolic pathways. GCLC is the catalytic core of GCL and determines the overall activity of the enzyme. Given the central role of oxidative stress in neurodegenerative diseases, GCLC has emerged as a gene of significant interest in Alzheimer's disease, Parkinson's disease, and other neurological conditions characterized by redox imbalance [@meister1994].

Molecular Function and Mechanism

The GCL Enzyme Complex

GCLC forms a functional heterodimer with GCLM (glutamate-cysteine ligase modifier subunit):

Catalytic Subunit (GCLC):

• Contains the active site
• Binds glutamate and cysteine substrates
• Catalyzes ATP-dependent γ-glutamylcysteine formation
• Contains approximately 637 amino acids

• Increases enzyme efficiency
• Reduces Ki for feedback inhibition by GSH
• Modulates response to oxidative stress
• Contains approximately 219 amino acids

Catalytic Mechanism

GCLC catalyzes the following reaction:

Glutamate + Cysteine + ATP → γ-Glutamylcysteine + ADP + Pi

The reaction proceeds through:

Regulation of GCLC

GCLC expression and activity are regulated at multiple levels:

Transcriptional Regulation:

• Nrf2/ARE pathway: Primary transcriptional activator
• AP-1 transcription factor: Induced by oxidative stress
• NF-κB: Can both activate and repress depending on context

• mRNA stability: Affected by redox state
• Alternative splicing: Produces variant isoforms

• Feedback inhibition: GSH inhibits GCLC activity
• Oxidative modification: Cysteine residues can be modified
• Phosphorylation: Can affect enzyme activity

Role in Glutathione Synthesis

The glutathione synthesis pathway consists of two ATP-dependent steps:

GCLC's regulation of the first step makes it the primary control point for cellular GSH levels.

Physiological Role in Antioxidant Defense

Glutathione Functions

Glutathione serves multiple critical functions:

Brain Antioxidant Defense

The brain is particularly vulnerable to oxidative stress due to:

• High oxygen consumption: ~20% of body oxygen despite 2% body mass
• High lipid content: Susceptible to lipid peroxidation
• Limited regenerative capacity: Post-mitotic neurons
• Excitotoxicity: Generates additional ROS
• Mitochondrial density: High OXPHOS generates ROS

Disease Associations

Parkinson's Disease

GCLC is highly relevant to PD pathogenesis:

Evidence:

• Reduced GSH in substantia nigra: Documented in PD postmortem brain
• GCLC expression alterations: Variable reports in PD brain
• Genetic associations: Some GCLC variants increase PD risk
• Nrf2 pathway dysfunction: Impaired antioxidant response

• Dopaminergic neuron vulnerability: High ROS production
• Mitochondrial dysfunction: Contributes to oxidative stress
• Neuroinflammation: Generates ROS and RNS

• Nrf2 activators to enhance GCLC expression
• Glutathione precursors
• Antioxidant therapies

Alzheimer's Disease

Oxidative stress is a key feature of AD:

• Amyloid-beta toxicity: Generates oxidative stress
• Tau pathology: Associated with oxidative damage
• Synaptic dysfunction: ROS affects neurotransmission
• Energy metabolism: Mitochondrial dysfunction

• Boosting GCLC expression
• Enhancing glutathione levels
• Nrf2-activating compounds

Amyotrophic Lateral Sclerosis (ALS)

• Motor neuron oxidative stress: Central to pathogenesis
• GCLC alterations: Documented in ALS models
• Glutathione depletion: Observed in ALS tissue
• Therapeutic targeting: Nrf2 activators in trials

Other Neurodegenerative Conditions

• Huntington's disease: Glutathione alterations
• Multiple sclerosis: Demyelination involves oxidative stress
• Friedreich's ataxia: Frataxin deficiency affects redox
• Wilson disease: Copper-induced oxidative stress

Expression Pattern

Tissue Distribution

GCLC is expressed in most tissues:

• Liver: Highest expression - primary glutathione production
• Kidney: Significant expression
• Brain: Neurons and glia
• Lung: Epithelial cells
• Heart: Myocardium
• Intestine: Epithelial cells

Brain Expression

• Neurons: High expression in most neuronal types
• Astrocytes: Important for neuronal GSH support
• Microglia: Lower expression
• Oligodendrocytes: Variable expression

Regional Expression

• Cortex: High expression
• Hippocampus: CA1-CA3 neurons
• Cerebellum: Purkinje cells
• Substantia nigra: Dopaminergic neurons

Cellular Localization

• Cytoplasm: Primary localization
• Mitochondria: Some mitochondrial GSH pool
• Nucleus: May have nuclear functions

Therapeutic Implications

Targeting GCLC

• Sulforaphane (broccoli-derived)
• Bardoxolone methyl
• Oltipraz
• Dimethyl fumarate

• N-acetylcysteine (NAC)
• Cysteine derivatives
• Glutathione esters

• GCLC delivery
• Nrf2 gene therapy approaches

Clinical Applications

• Neurodegenerative disease: Nrf2 activators in trials
• Chemoprotection: Protecting normal tissue during chemo
• Aging: Age-related GSH decline
• Metabolic diseases: Oxidative stress in diabetes

Interaction Network

GCLC interacts with:

• GCLM: Modifier subunit
• Nrf2: Transcription factor
• Keap1: Negative regulator of Nrf2
• c-Fos/c-Jun: AP-1 transcription factors
• NF-κB: Inflammatory signaling
• Glutathione synthetase (GSS): Downstream enzyme
• SOD1: Superoxide dismutase
• GPx: Glutathione peroxidase

Diagnostic Significance

• Genetic testing: For GCLC variants
• Biomarker potential: Expression as disease indicator
• Therapeutic response: Marker of antioxidant therapy efficacy

Cross-Links

• [Glutathione Metabolism](/mechanisms/glutathione-metabolism)
• [Oxidative Stress](/mechanisms/oxidative-stress-neurodegeneration)
• [Nrf2 Pathway](/mechanisms/nrf2-antioxidant-pathway)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

See Also

• [GCLM Gene](/genes/gclm)
• [GSS Gene](/genes/gss)
• [Glutathione](/mechanisms/glutathione)
• [Antioxidant Defense](/mechanisms/antioxidant-defense)
• [Nrf2 Pathway](/mechanisms/nrf2-pathway)

External Links

• [NCBI Gene: GCLC](https://www.ncbi.nlm.nih.gov/gene/2729)
• [UniProt: P48506](https://www.uniprot.org/uniprot/P48506)
• [Ensembl: ENSG00000001036](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000001036)
• [OMIM: 606483](https://www.omim.org/entry/606483)

References

Pathway Diagram

Key molecular relationships involving gclc from the SciDEX knowledge graph:

Pathway Diagram

The following diagram shows the key molecular relationships involving gclc discovered through SciDEX knowledge graph analysis: